Thalidomide use and digital gangrene.
Kang
Tyler Y
TY
Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA.
Lowe
Christopher J
CJ
Sekeres
Mikkael A
MA
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects; D002908:Chronic Disease; D003646:Debridement; D005260:Female; D005385:Fingers / Q000098:blood supply* / Q000601:surgery; D005734:Gangrene / Q000139:chemically induced* / Q000601:surgery; D006801:Humans; D008875:Middle Aged; D055728:Primary Myelofibrosis / Q000188:drug therapy; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects*
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D013792:Thalidomide